Tenders

Open Framework Agreement on Drug Discounts in Accordance with Section 130A Paragraph 8 Sentence 1 Sgb V with the Possibility of Joining at any Time, So-Called Approval Model 2024-05

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion Within the Framework of the So-Called Open House Procedure.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Lisdexamfetamine

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for Various Active Ingredients/Combinations with the Possibility of Conclusion at any Time as Part of the So-Called Open House Procedure

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Brimonidine in the Dosage Form Edp

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V by Means of a So-Called Open House Model for Medicines with the Trade Name Grazax(R) (Atc Code According to Who: V01aa02)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Pegfilgrastim (Atc Code According to Who: L03aa13)

V169_2024 - Wi-Aman - 3D Metal Printer (Care-O-Sene)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Somatropin (Atc Code According to Who: H01ac01)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Epinephrine in the Dosage Form Ilo